細胞材料開発室サイト
検索画面


戻る 戻る
APS0001 : iPS-MEF-Ng-20D-17  update : 2018/07/31
CommentMouse induced pluripotent stem (iPS) cell line. Expressing GFP by Nanog promoter. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for-profit organization.
特性(日) マウス人工多能性幹(iPS)細胞株。NanogプロモーターにてGFPを発現している。営利機関は、 京都大学iPS細胞研究所から配布。
寄託者特性(英)
寄託者特性(日)
使用条件f
使用条件(英)1) The RECIPIENT belongs to a not-for-profit academic organization (i.e., a university or another institution of higher education or any nonprofit scientific or educational organization, including government agencies). 2) The RECIPIENT should read the GFP Transfer License contracted between the RIKEN BRC and GE Healthcare Bio-Sciences. 3) Attach TERMS and CONDITIONS to MTA (C-0034) .
使用条件(日)1) 利用者は学術機関に所属している者に限る。2) GE Healthcare Bio-Sciences社とBRCとのGFP Transfer License 締結 を確認の上、手続きを取ること。 3) 別紙1を提供同意書 (C-0028) に添付すること。
提供申込書類 依頼書C-0027.pdf   同意書C-0028.pdf  
提供同意書は、使用機関及び使用内容に応じて二種類あります。該当する提供同意書をご使用ください(詳細)。特許等の取得及び商業利用等は別途ご相談(cellbank.brc@riken.jp)を承ります。
寄託関連情報 ライセンス GFP
細胞基本情報 寄託者 http://www.cira.kyoto-u.ac.jp/
樹立者 Yamanaka, Shinya
寄託日 2007
別名 RCB2698
動物種 mouse < Mammals
性別 Male
embryo
採取組織 embryonic fibroblast
細胞分類 iPS
遺伝子改変の有無 recombinant
外来遺伝子 pMXs, Oct3/4, Sox2, Klf4, c-Myc, Nanog-GFP-IRES-Puro^r
細胞寿命 infinite
細胞形態 ES-like
細胞培養情報
寄託時情報
ロット情報
培地・試薬情報 培地・試薬一覧はこちらをご覧ください。
培養形態 Adherent cells
培地 DMEM (high glucose, without Sodium Pyruvate) + 15% FBS + 0.1mM NEAA + 0.1mM 2-Mercaptoethanol + 1000U/ml mouse LIF
抗生物質 Free
継代方法 0.25% trypsin + 0.02% EDTA
培養容器のコーティング 0.1% gelatin coated dish
播種細胞数 2 x 10^(6) cells/100 mm dish
継代または培地交換頻度 Subculture : once/2-3 days, Medium Renewal : every day
培養最適温度 37 ℃
二酸化炭素濃度 5 %
フィーダー細胞 MEF
フィーダー細胞の処理方法 X-rays 5000R (or MMC)
フィーダー細胞の播種数 1-2 x 10^(6) cells/100 mm dish
凍結培地 Medium + 10% DMSO
凍結方法 Slow freezing
マイコプラズマ (-)
アイソザイム検査 LD, NP
画像情報
寄託時情報
ロット情報
文献情報 Reference(英) 0件
Reference(日) 0件
利用者成果(英) 31件
利用者成果(日) 1件

トップへページトップへ
Reference(英)

トップへページトップへ
Reference(日)

トップへページトップへ
利用者成果(英)
Nair N, Calle AS, Zahra MH, Prieto-Vila M, Oo AKK, Hurley L, Vaidyanath A, Seno A, Masuda J, Iwasaki Y, Tanaka H, Kasai T, Seno M.  A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment.  Sci Rep  2017  7:6838  PubMed ID: 28754894
Wu J, Platero-Luengo A, Sakurai M, Sugawara A, Gil MA, Yamauchi T, Suzuki K, Bogliotti YS, Cuello C, Morales Valencia M, Okumura D, Luo J, Vilarino M, Parrilla I, Soto DA, Martinez CA, Hishida T, Sanchez-Bautista S, Martinez-Martinez ML, Wang H, Nohalez A, Aizawa E, Martinez-Redondo P, Ocampo A, Reddy P, Roca J, Maga EA, Esteban CR, Berggren WT, Nunez Delicado E, Lajara J, Guillen I, Guillen P, Campistol JM, Martinez EA, Ross PJ, Izpisua Belmonte JC.  Interspecies Chimerism with Mammalian Pluripotent Stem Cells.  Cell  2017  168:473-486.e15  PubMed ID: 28129541
Ikeda M, Imaizumi M, Yoshie S, Otsuki K, Miyake M, Hazama A, Wada I, Omori K.  Regeneration of tracheal epithelium using mouse induced pluripotent stem cells.  Acta Otolaryngol.  2016  136:373-8  PubMed ID: 26755348
T Kosawada, T Koizumi, K Ugajin, Z Feng, K Goto  Novel three-dimensional micro vibration actuator for imposing dynamic stimulations to promote differentiation of iPS cells.  Microsyst Technol  2016  22:45-56 
Otsu K, Kishigami R, Oikawa-Sasaki A, Fukumoto S, Yamada A, Fujiwara N, Ishizeki K, Harada H.  Differentiation of induced pluripotent stem cells into dental mesenchymal cells.  Stem Cells Dev.  2011  21:1156-64  PubMed ID: 22085204
Tashiro K, Kawabata K, Omori M, Yamaguchi T, Sakurai F, Katayama K, Hayakawa T, Mizuguchi H.  Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction.  Stem Cell Res  2011  8:300-11  PubMed ID: 22000550
Hayashi K, Hashimoto M, Koda M, Naito AT, Murata A, Okawa A, Takahashi K, Yamazaki M.  Increase of sensitivity to mechanical stimulus after transplantation of murine induced pluripotent stem cell-derived astrocytes in a rat spinal cord injury model.  J Neurosurg Spine  2011  15:582-93  PubMed ID: 21854127
Ishizuka T, Watanabe Y.  α?-Adrenoceptor stimulation enhances leukemia inhibitory factor-induced proliferation of mouse-induced pluripotent stem cells.  Eur. J. Pharmacol.  2011  668:42-56  PubMed ID: 21745467
Hasegawa Y, Takahashi N, Forrest AR, Shin JW, Kinoshita Y, Suzuki H, Hayashizaki Y.  CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells.  Stem Cells  2011  29:1196-205  PubMed ID: 21681859
Lei F, Zhao B, Haque R, Xiong X, Budgeon L, Christensen ND, Wu Y, Song J.  In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.  Cancer Res.  2011  71:4742-7  PubMed ID: 21628492
Kitazawa A, Shimizu N.  Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia.  N Biotechnol  2011  28:326-33  PubMed ID: 21477670
Kasuda S, Tatsumi K, Sakurai Y, Kato J, Taminishi S, Takeda T, Ohashi K, Okano T, Hatake K, Shima M.  Expression of coagulation factors from murine induced pluripotent stem cell-derived liver cells.  Blood Coagul. Fibrinolysis  2011  22:271-9  PubMed ID: 21415711
Yukawa H, Ikeuchi M, Noguchi H, Miyamoto Y, Ikuta K, Hayashi S.  Embryonic body formation using the tapered soft stencil for cluster culture device.  Biomaterials  2011  32:3729-38  PubMed ID: 21354615
Chan SS, Li HJ, Hsueh YC, Lee DS, Chen JH, Hwang SM, Chen CY, Shih E, Hsieh PC.  Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells.  PLoS ONE  2011  5:e14414  PubMed ID: 21203390
Yamashita T, Kawai H, Tian F, Ohta Y, Abe K.  Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain.  Cell Transplant  2010  20:883-91  PubMed ID: 21054935
Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, Yuasa T, Shahid JM, Hassan RA, Hassan WA, Nakaji S, Nishikawa Y, Kondo E, Yamamoto K, Fox IJ, Kobayashi N.  Hepatic differentiation of mouse iPS cells in vitro.  Cell Transplant  2010  19:841-7  PubMed ID: 20955659
Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, Yuasa T, Shahid JM, Hassan RA, Hassan WA, Nakaji S, Nishikawa Y, Kondo E, Yamamoto K, Kobayashi N.  Comparative analysis of endoderm formation efficiency between mouse ES cells and iPS cells.  Cell Transplant  2010  19:831-9  PubMed ID: 20955658
Suzuki H, Shibata R, Kito T, Ishii M, Li P, Yoshikai T, Nishio N, Ito S, Numaguchi Y, Yamashita JK, Murohara T, Isobe K.  Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells.  BMC Cell Biol.  2010  11:72  PubMed ID: 20860813
Yukawa H, Noguchi H, Nakase I, Miyamoto Y, Oishi K, Hamajima N, Futaki S, Hayashi S.  Transduction of cell-penetrating peptides into induced pluripotent stem cells.  Cell Transplant  2010  19:901-9  PubMed ID: 20587149
Tokumoto Y, Ogawa S, Nagamune T, Miyake J.  Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.  J. Biosci. Bioeng.  2010  109:622-8  PubMed ID: 20471604
Kawai H, Yamashita T, Ohta Y, Deguchi K, Nagotani S, Zhang X, Ikeda Y, Matsuura T, Abe K.  Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain.  J. Cereb. Blood Flow Metab.  2010  30:1487-93  PubMed ID: 20216552
Kitadani J, Ojima T, Iwamoto H, Tabata H, Nakamori M, Nakamura M, Hayata K, Katsuda M, Miyajima M, Yamaue H.  Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells.  Sci Rep  2018  8:4569  PubMed ID: 29545628
Mullen PA.  Presentation of clean livestock for slaughter.  Vet. Rec.  1997  140:634  PubMed ID: 9228699
Yan Y, Yin P, Gong H, Xue Y, Zhang G, Fang B, Chen Z, Li Y, Yang C, Huang Z, Yang X, Ge J, Zou Y.  Nucleosome Assembly Protein 1-Like 1 (Nap1l1) Regulates the Proliferation of Murine Induced Pluripotent Stem Cells.  Cell. Physiol. Biochem.  2016  38:340-50  PubMed ID: 26824453
Miyamoto D, Nakazawa K.  Differentiation of mouse iPS cells is dependent on embryoid body size in microwell chip culture.  J. Biosci. Bioeng.  2016  122:507-12  PubMed ID: 27090344
Shirouzu Y, Yanai G, Yang KC, Sumi S.  Effects of Activin in Embryoid Bodies Expressing Fibroblast Growth Factor 5.  Cell Reprogram  2016  18:171-86  PubMed ID: 27253628
Higuchi S, Yoshina S, Mitani S.  Inhibition of the integrin signal constitutes a mouse iPS cell niche.  Dev. Growth Differ.  2016  58:586-99  PubMed ID: 27633818
Ogawa Y, Kaizu K, Yanagi Y, Takada S, Sakuraba H, Oishi K.  Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.  PLoS ONE  2017  12:e0178978  PubMed ID: 28575132
Osawa Y, Miyamoto T, Ohno S, Ohno E.  Morphological Analysis of Live Undifferentiated Cells Derived from Induced Pluripotent Stem Cells.  Stem Cells Dev.  2018  27:1-9  PubMed ID: 28978257
  Abstract 925: Tumorigenesis of murine iPS cell is prevented by iron depletion with downregulation of stemness markers        PubMed ID:
  Craniofacial Bone Regeneration using iPS Cell-Derived Neural Crest Like Cells        PubMed ID:

トップへページトップへ
利用者成果(日)
Ozeki N, Hase N, Mogi M, Nakata K  幹細胞由来高純度象牙芽細胞を用いた in vitro 歯髄炎モデルにおける MMP-3 の新規知見. (New Findings of MMP-3: Application of Purified Odontoblasts Derived from Stem Cells as an in vitro Pulpitis Model.)  The Japanese Journal of Conservative Dentistry  2015  58:347-355 



戻る 戻る 理研トップページへ